Yooze Snooze & Miss The Nooze | Arthritis Information

01 February 2008

Gene Linked To Increased Risk Of Developing Inflammatory Arthritis May Also Increase Patients' Risk Of Dying From Cardiovascular Disease

A Pathway Discovered To Turn Off Immune System Cells

Rheumatic Complaints Not Just A Problem For The Western World

29 January 2008

Bone Medical Developing Potentially First Rheumatoid Arthritis Drug To Treat Both IL6 And TNF, Australia

28 January 2008

Arthritis Foundation Launches Year-Long Recognition Of 60th Anniversary

Genentech And Biogen Idec Announce Positive Results From A Phase 3 Trial Of Rituxan In Patients With Rheumatoid Arthritis Who Inadequately Responded

25 January 2008

MabThera Meets Study Primary Endpoint In Improving Disease Symptoms When Used As First Biologic Therapy In Patients With Rheumatoid Arthritis

Although Comfort And Mobility Improved, Arthritic Knees Remain Painful After Arthroscopic Surgery

Heart Rhythm May Be Disrupted By Popular Arthritis Drug

24 January 2008

Arthritis Foundation Announces Top 10 Arthritis Advances Of 2007

Lev -

Medical News today is a PR service. They package the info like it's news...it's not news.

Everrthing you just posted says something like this -

Bone Medical Limited is an international biopharmaceutical development company positioned to exploit the growing market in the treatment of bone disease particularly in osteoporosis and arthritis.

Sorry, sweetie, you may want to be 'exploited'. I want a cure.

That being said - the actual study for the first one looks promising. I'd like to campare that to APers. My CRP dropped to normal in 3 - 4 months on AP. That's why I'd like to see how it compares on the biologics. Even tho that study is paid for by Amgen...it might show again how the numbers REALLY line up.

Pip